Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mazza

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
Thorax|September 13, 2013
Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective studyPierre-Olivier Bridevaux, J-D Aubert, P M Soccal, et al.
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
American Journal of Clinical Oncology|April 1, 1995
The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapyW R Friedenberg, H J Miller, J J Marx, et al.
JAMA|November 18, 1983
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacementR D Sautter, E L Koch, W O Myers, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
Acta Haematologica|July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2022
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosisT Mercier, V Desfontaine, S Cruchon, et al.
Blood|March 1, 2019
A gene-based recessive diplotype exome scan discovers <i>FGF6</i>, a novel hepcidin-regulating iron-metabolism geneShicheng Guo, Shuai Jiang, Narendranath Epperla, et al.
Archives of Internal Medicine|February 1, 1979
The limited utility of fibrinogen I 125 leg scanningR D Sautter, D E Larson, S K Bhattacharyya, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
Thorax|September 13, 2013
Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective studyPierre-Olivier Bridevaux, J-D Aubert, P M Soccal, et al.
Leukemia|January 1, 1992
Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology GroupP A Cassileth, J W Andersen, J M Bennett, et al.
American Journal of Clinical Oncology|April 1, 1995
The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapyW R Friedenberg, H J Miller, J J Marx, et al.
JAMA|November 18, 1983
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacementR D Sautter, E L Koch, W O Myers, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
Acta Haematologica|July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 14, 2022
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosisT Mercier, V Desfontaine, S Cruchon, et al.
Blood|March 1, 2019
A gene-based recessive diplotype exome scan discovers <i>FGF6</i>, a novel hepcidin-regulating iron-metabolism geneShicheng Guo, Shuai Jiang, Narendranath Epperla, et al.
Archives of Internal Medicine|February 1, 1979
The limited utility of fibrinogen I 125 leg scanningR D Sautter, D E Larson, S K Bhattacharyya, et al.
Pageof 16